{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:20:31Z","timestamp":1791951631470,"version":"4.3.4"},"reference-count":169,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>An estimated 15\u201320% of reproductive-age women are affected by polycystic ovary syndrome (PCOS). PCOS is associated with substantial metabolic and cardiovascular long-term consequences. In young women with PCOS, several cardiovascular risk factors may be found, including chronic inflammation, high blood pressure, and elevated leukocytes. These women are at an increased risk of cardiovascular diseases (CVD), not only during the reproductive years, but also with aging and menopause; therefore, the early prevention and treatment of future cardiovascular adverse effects are necessary. The fundamental characteristic of PCOS is hyperandrogenemia, which is associated with increased pro-inflammatory cytokines and T lymphocytes. Whether these factors play a role in the pathophysiology of hypertension, a risk factor of CVD, due to PCOS is not well established. This review will briefly discuss how a modest increase in androgens in females is linked to the development of hypertension through pro-inflammatory cytokines and T lymphocyte subsets and the promotion of renal injury. Moreover, it reveals a few existing research gaps in this area, including the lack of specific therapy directed at androgen-induced inflammation and immune activation, thus emphasizing the necessity to explore the systemic inflammation in women with PCOS to halt the inevitable inflammatory process targeting the underlying abnormalities of CVD.<\/jats:p>","DOI":"10.3390\/life13041010","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T01:32:03Z","timestamp":1681435923000},"page":"1010","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes"],"prefix":"10.3390","volume":"13","author":[{"given":"Mohadetheh","family":"Moulana","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Human Behavior, Women\u2019s Health Research Center, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile","volume":"84","author":"Kouli","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Calvo","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","first-page":"39","article-title":"Metabolic and cardiovascular consequences of polycystic ovary syndrome","volume":"60","author":"Orio","year":"2008","journal-title":"Minerva Ginecol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment","volume":"14","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"bnaa010","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome","volume":"41","author":"Padmanabhan","year":"2020","journal-title":"Endocr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2265.1992.tb02295.x","article-title":"Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome","volume":"37","author":"Conway","year":"1992","journal-title":"Clin. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: Criteria for defining polycystic ovary syndrome: An Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2005-2327","article-title":"Increased activation of nuclear factor \u03baB triggers inflammation and insulin resistance in polycystic ovary syndrome","volume":"91","author":"Rote","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13697130903003842","article-title":"Cardiovascular risk and events in polycystic ovary syndrome","volume":"12","author":"Carmina","year":"2009","journal-title":"Climacteric"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12933-018-0680-5","article-title":"Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome","volume":"17","author":"Glintborg","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12958-020-00576-1","article-title":"Risk of hypertension in women with polycystic ovary syndrome: A systemic review, meta-analysis and meta-regression","volume":"18","author":"Amiri","year":"2020","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2008.08.037","article-title":"Sex hormone levels and subclinical atherosclerosis in postmenopausal women: The Multi-Ethnic Study of Atherosclerosis","volume":"204","author":"Ouyang","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.maturitas.2010.09.005","article-title":"Cardiovascular risk in postmenopausal women with the polycystic ovary syndrome","volume":"68","author":"Lambrinoudaki","year":"2011","journal-title":"Maturitas"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0015-0282(99)00641-X","article-title":"Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome","volume":"73","author":"Winters","year":"2000","journal-title":"Fertil. Steril."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1210\/jc.2011-1677","article-title":"Cardiovascular disease and risk factors in PCOS women of postmenopausal age: A 21-year controlled follow-up study","volume":"96","author":"Schmidt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.fertnstert.2017.09.004","article-title":"Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: A long-term population-based follow-up study","volume":"108","author":"Jaliseh","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/09513590.2019.1650337","article-title":"Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"36","author":"Amiri","year":"2020","journal-title":"Gynecol. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1210\/jc.2005-2430","article-title":"Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome","volume":"91","author":"Lo","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/jc.2004-0751","article-title":"Endothelial dysfunction in young women with PCOS: Relationship with insulin resistance and low-grade chronic inflammation","volume":"89","author":"Tarkun","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/jc.2004-0628","article-title":"The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome","volume":"90","author":"Orio","year":"2005","journal-title":"J. Clin. Endocrinol. Metabol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1210\/jc.2017-02421","article-title":"High androgens in postmenopausal women and the risk for atherosclerosis and cardiovascular disease: The Rotterdam Study","volume":"103","author":"Meun","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijcard.2014.06.079","article-title":"Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"176","author":"Anderson","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1161\/HYPERTENSIONAHA.106.083972","article-title":"Relationship between androgen levels and blood pressure in young women with polycystic ovary syndrome","volume":"49","author":"Chen","year":"2007","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.jhh.1000949","article-title":"Fifty years of Framingham Study contributions to understanding hypertension","volume":"14","author":"Kannel","year":"2000","journal-title":"J. Hum. Hypertens."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/jc.2007-0190","article-title":"Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome","volume":"92","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_27","first-page":"1177","article-title":"Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles","volume":"101","author":"Amato","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Gao, L., Gu, Y., and Yin, X. (2016). High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164021"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7827-9-7","article-title":"Is interleukin-18 associated with polycystic ovary syndrome?","volume":"9","author":"Yang","year":"2011","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.15171\/jnp.2017.04","article-title":"Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome","volume":"6","author":"Foroozanfard","year":"2017","journal-title":"J. Nephropathol."},{"key":"ref_31","first-page":"4092470","article-title":"Inflammatory Markers in Women with Polycystic Ovary Syndrome","volume":"4","author":"Rudnicka","year":"2020","journal-title":"BioMed Res. Int."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rudnicka, E., Suchta, K., Grymowicz, M., Calik-Ksepka, A., Smolarczyk, K., Duszewska, A.M., Smolarczyk, R., and Meczekalski, B. (2021). Chronic Low Grade Inflammation in Pathogenesis of PCOS. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073789"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13048-021-00867-0","article-title":"The abnormal level of HSP70 is related to Treg\/Th17 imbalance in PCOS patients","volume":"14","author":"Yang","year":"2020","journal-title":"J. Ovarian. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.mgene.2016.08.001","article-title":"Interleukin 10 (\u20131082 G\/A) and (\u2013819 C\/T) gene polymorphisms in Egyptian women with polycystic ovary syndrome (PCOS)","volume":"9","author":"Talaat","year":"2016","journal-title":"Meta Gene"},{"key":"ref_35","first-page":"175","article-title":"T helper cells profile and CD4+CD25+Foxp3+regulatory T cells in polycystic ovary syndrome","volume":"15","author":"Nasri","year":"2018","journal-title":"Iran J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in polycystic ovary syndrome: Underpinning of insulin resistance and ovarian dysfunction","volume":"77","year":"2012","journal-title":"Steroids"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11906-010-0096-4","article-title":"Central adiposity, systemic inflammation, and the metabolic syndrome. Curr","volume":"12","author":"Elks","year":"2010","journal-title":"Hypertens. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/met.2009.0116","article-title":"Hypertension, Obesity, and Inflammation: The complex designs of a deadly trio","volume":"8","author":"Rizvi","year":"2010","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10753-010-9219-y","article-title":"Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults","volume":"34","author":"Hermsdorff","year":"2011","journal-title":"Inflammation"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Aboeldalyl, S., James, C., Seyam, E., Ibrahim, E.M., Shawki, H.E., and Amer, S. (2021). The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052734"},{"key":"ref_41","first-page":"165","article-title":"Evaluation of TNF-\u03b1 and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol","volume":"21","author":"Ghowsi","year":"2018","journal-title":"Iran J. Basic. Med. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.lfs.2019.01.048","article-title":"Immunophenotypic profile of leukocytes in hyperandrogenemic female rat an animal model of polycystic ovary syndrome","volume":"1","author":"Moulana","year":"2019","journal-title":"Life Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"103345","DOI":"10.1016\/j.jri.2021.103345","article-title":"Increased pro-inflammatory cytokines in ovary and effect of \u03b3-linolenic acid on adipose tissue inflammation in a polycystic ovary syndrome model","volume":"146","author":"Prabhu","year":"2021","journal-title":"J. Reprod. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.5301\/jsrd.5000265","article-title":"Interleukin-6 as a Multifunctional Regulator: Inflammation, Immune Response, and Fibrosis","volume":"2","author":"Choy","year":"2017","journal-title":"J. Scleroderma Relat. Disord."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"780616","DOI":"10.1155\/2014\/780616","article-title":"A possible change process of inflammatory cytokines in the prolonged chronic stress and its ultimate implications for health","volume":"2014","author":"Tian","year":"2014","journal-title":"Sci. World J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/01443615.2011.553693","article-title":"Polycystic ovary syndrome and the peripheral blood white cell count","volume":"31","author":"Herlihy","year":"2011","journal-title":"J. Obstet. Gynaecol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.fertnstert.2011.01.129","article-title":"CD4+CD28null T lymphocytes are expanded in young women with polycystic ovary syndrome","volume":"95","author":"Niccoli","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2265.2012.04454.x","article-title":"Leukocytosis in women with polycystic ovary syndrome (PCOS) is incompletely explained by obesity and insulin resistance","volume":"78","author":"Phelan","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"ref_49","first-page":"782","article-title":"The changes of Th17 and Treg cells in peripheral blood of patients with polycystic ovary syndrome","volume":"7","author":"Guo","year":"2014","journal-title":"Zhongguo Weishengtaxixue Zazhi\/Chin. J. Microecol."},{"key":"ref_50","first-page":"91","article-title":"White blood cells levels and PCOS: Direct and indirect relationship with obesity and insulin resistance, but not with hyperandrogenemia","volume":"14","author":"Papolou","year":"2015","journal-title":"Hormones"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"5894768","DOI":"10.1155\/2020\/5894768","article-title":"Immunophenotypic Profiles in Polycystic Ovary Syndrome","volume":"2020","author":"Hu","year":"2020","journal-title":"Mediators Inflamm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0015-0282(03)00344-3","article-title":"Correlations between concentrations of interleukin-12 and interleukin-13 and lymphocyte subsets in the follicular fluid of women with and without polycystic ovary syndrome","volume":"79","author":"Gallinelli","year":"2003","journal-title":"Fertil. Steril."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.167.4.2060","article-title":"Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production","volume":"167","author":"Liva","year":"2001","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1210\/endo.142.3.8032","article-title":"Androgen receptors in thymic epithelium modulate thymus size and thymocyte development","volume":"142","author":"Olsen","year":"2001","journal-title":"Endocrinology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0039-128X(02)00055-7","article-title":"Developmental regulation of intracellular and surface androgen receptors in T cells","volume":"67","author":"Benten","year":"2002","journal-title":"Steroids"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/1096-9896(0000)9999:9999<::AID-PATH803>3.0.CO;2-W","article-title":"Localization of androgen receptor expression in human bone marrow","volume":"193","author":"Mantalaris","year":"2001","journal-title":"J. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11864-018-0519-z","article-title":"Androgen therapy for acute myeloid and hairy cell leukemia","volume":"19","author":"Wiernik","year":"2018","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1091\/mbc.E14-08-1323","article-title":"Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+ regulatory T-cells","volume":"26","author":"Walecki","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin-17","volume":"6","author":"Park","year":"2005","journal-title":"Nat. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4049\/jimmunol.175.1.404","article-title":"Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: Implications for airway inflammation in cystic fibrosis","volume":"175","author":"McAllister","year":"2005","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00011-007-6187-2","article-title":"Is cystic fibrosis a TH17 disease?","volume":"56","author":"Dubin","year":"2007","journal-title":"Inflamm. Res."},{"key":"ref_62","first-page":"903","article-title":"T(H)-17 differentiation: Of mice and men Nat","volume":"8","author":"Laurence","year":"2007","journal-title":"Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.cell.2010.02.021","article-title":"Th17 and regulatory T cells in mediating and restraining inflammation","volume":"140","author":"Littman","year":"2010","journal-title":"Cell"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Fasching, P., Stradner, M., Graninger, W., Dejaco, C., and Fessler, J. (2017). Therapeutic potential of targeting the Th17\/Treg axis in autoimmune disorders. Molecules, 22.","DOI":"10.3390\/molecules22010134"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"678355","DOI":"10.3389\/fimmu.2021.678355","article-title":"The Alterations in and the Role of the Th17\/Treg Balance in Metabolic Diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.fertnstert.2012.08.015","article-title":"CD4(+)CD28(null) T lymphocyte frequency, a new marker of cardiovascular risk: Relationship with polycystic ovary syndrome phenotypes","volume":"98","author":"Moro","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ejogrb.2015.12.003","article-title":"Differential expression profile of immunological cytokines in local ovary in patients with polycystic ovarian syndrome: Analysis by flow cytometry","volume":"197","author":"Qin","year":"2016","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/jc.2014-2401","article-title":"Reduced Tregs in peripheral blood of PCOS patients\u2014A consequence of aberrant Il2 signaling","volume":"100","author":"Krishna","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1146\/annurev.immunol.21.120601.140942","article-title":"Molecular mechanisms regulating Th1 immune responses","volume":"21","author":"Szabo","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.109.145094","article-title":"Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction","volume":"55","author":"Madhur","year":"2010","journal-title":"Hypertension"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/hq1201.100220","article-title":"Immune mechanisms in atherosclerosis","volume":"21","author":"Hansson","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nri1027","article-title":"Regulatory T cells in transplantation tolerance","volume":"3","author":"Wood","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","article-title":"Imbalance of regulatory T cells in human autoimmune diseases","volume":"117","author":"Dejaco","year":"2006","journal-title":"Immunology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbi.2008.11.002","article-title":"Neonatal testosterone imprinting affects thymus development and leads to phenotypic rejuvenation and masculinization of the peripheral blood T-cell compartment in adult female rats","volume":"23","author":"Leposavic","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/BF03401644","article-title":"The repertoire of CD4+ CD28\u2212 T cells in rheumatoid arthritis","volume":"2","author":"Schmidt","year":"1996","journal-title":"Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.4049\/jimmunol.167.6.3231","article-title":"Down-regulation of CD28 expression by TNF-\u03b1","volume":"167","author":"Bryl","year":"2001","journal-title":"J. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0402-379","article-title":"Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections","volume":"8","author":"Appay","year":"2002","journal-title":"Nat. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/art.1780400615","article-title":"Expansion of unusual CD4+ T cells in severe rheumatoid arthritis","volume":"40","author":"Martens","year":"1997","journal-title":"Arthritis Rheum."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.molmed.2004.01.002","article-title":"T-cell senescence: A culprit of immune abnormalities in chronic inflammation and persistent infection","volume":"10","author":"Vallejo","year":"2004","journal-title":"Trends. Mol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/01.ATV.0000167520.41436.c0","article-title":"High prevalence of circulating CD4+CD28\u2212 T-cells in patients with small abdominal aortic aneurysms","volume":"25","author":"Duftner","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1164\/rccm.200701-013OC","article-title":"CD28 Down-regulation on CD4 T-cells is a marker for graft dysfunction in lung transplant recipients","volume":"178","author":"Studer","year":"2008","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1161\/01.CIR.101.25.2883","article-title":"Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes","volume":"101","author":"Liuzzo","year":"2000","journal-title":"Circulation"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.jacc.2007.06.040","article-title":"Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events","volume":"50","author":"Liuzzo","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.4049\/jimmunol.161.2.1018","article-title":"Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28\u2212 T cells from rheumatoid arthritis patients","volume":"161","author":"Schirmer","year":"1998","journal-title":"J. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4049\/jimmunol.168.3.1028","article-title":"Activation-induced expression of carcinoembryonic antigen-cell adhesion molecule 1 regulates mouse T lymphocyte function","volume":"168","author":"Nakajima","year":"2002","journal-title":"J. Immunol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1136\/jcp.2003.015495","article-title":"The perforin mediated apoptotic pathway in lung injury and fibrosis","volume":"57","author":"Miyazaki","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0047-6374(97)00161-9","article-title":"Functional properties of CD4+ CD28\u2212 T cells in the aging immune system","volume":"102","author":"Weyand","year":"1998","journal-title":"Mech. Ageing Dev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ki.2008.301","article-title":"Expansion of cytolytic CD4+CD28\u2212 T cells in end-stage renal disease","volume":"74","author":"Betjes","year":"2008","journal-title":"Kidney Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1681\/ASN.2009040400","article-title":"CMV seropositivity determines epoetin dose and hemoglobin levels in patients with CKD","volume":"20","author":"Betjes","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/hc0502.103348","article-title":"T-cell-mediated lysis of endothelial cells in acute coronary syndromes","volume":"105","author":"Nakajima","year":"2002","journal-title":"Circulation"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.4049\/jimmunol.179.10.6514","article-title":"CD4+CD28null T cells in autoimmune disease: Pathogenic features and decreased susceptibility to immunoregulation","volume":"179","author":"Thewissen","year":"2007","journal-title":"J. Immunol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3923\/pjbs.2019.393.399","article-title":"Association of Perforin and Granzyme-B Levels with Hyperandrogenism in Polycystic Ovary Syndrome: A Case-Control Study","volume":"22","author":"Zarei","year":"2019","journal-title":"Pak. J. Biol. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.HYP.17.3.323","article-title":"Leukocyte counts and activation in spontaneously hypertensive and normotensive rats","volume":"17","author":"Seiffge","year":"1991","journal-title":"Hypertension"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/01.HYP.34.1.113","article-title":"Preactivated peripheral blood monocytes in patients with essential hypertension","volume":"34","author":"Schreiber","year":"1999","journal-title":"Hypertension"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/HYPERTENSIONAHA.108.120253","article-title":"Immunology in hypertension, preeclampsia, and target-organ damage","volume":"54","author":"Verlohren","year":"2009","journal-title":"Hypertension."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MNH.0b013e3283360a2e","article-title":"T lymphocytes: A role in hypertension?","volume":"19","author":"Schiffrin","year":"2010","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1172\/JCI74084","article-title":"DC isoketal-modified proteins activate T cells and promote hypertension","volume":"124","author":"Kirabo","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1084\/jem.20171773","article-title":"The immunology of hypertension","volume":"215","author":"Norlander","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"R1282","DOI":"10.1152\/ajpregu.90992.2008","article-title":"Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosus","volume":"296","author":"Maric","year":"2009","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"893","DOI":"10.4049\/jimmunol.171.2.893","article-title":"Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2","volume":"171","author":"Brown","year":"2003","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.coi.2003.09.002","article-title":"Toll-like receptors: Balancing host resistance with immune tolerance","volume":"15","author":"Pasare","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/eji.1830200511","article-title":"Tumor necrosis factor-alpha and interleukin 6 synergistically induce T cell growth","volume":"20","author":"Kuhweide","year":"1990","journal-title":"Eur. J. Immunol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1161\/01.CIR.100.21.2135","article-title":"Perturbation of the T-cell repertoire in patients with unstable angina","volume":"100","author":"Liuzzo","year":"1999","journal-title":"Circulation"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0895-4356(00)00296-1","article-title":"White blood cell count: An independent predictor of coronary heart disease mortality among a national cohort","volume":"54","author":"Brown","year":"2001","journal-title":"J. Clin. Epidemiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2004.07.056","article-title":"Leukocyte count and coronary heart disease: Implications for risk assessment","volume":"44","author":"Madjid","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1902\/jop.2013.120483","article-title":"Is interleukin-17 involved in the interaction between polycystic ovary syndrome and gingival inflammation?","volume":"84","author":"Ozcaka","year":"2013","journal-title":"J. Periodontol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tcm.2010.02.004","article-title":"Role of the immune system in hypertensive target organ damage","volume":"19","author":"Kvakan","year":"2009","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004872-198506000-00011","article-title":"Immune system dysfunction contributes to the aetiology of spontaneous hypertension","volume":"3","author":"Norman","year":"1985","journal-title":"J. Hypertens."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"F38","DOI":"10.1152\/ajprenal.2001.281.1.F38","article-title":"Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition","volume":"281","author":"Quiroz","year":"2001","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"F191","DOI":"10.1152\/ajprenal.0197.2001","article-title":"Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats","volume":"282","author":"Quiroz","year":"2002","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.amjhyper.2005.05.034","article-title":"Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys","volume":"18","author":"Quiroz","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"R1136","DOI":"10.1152\/ajpregu.00298.2009","article-title":"T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats","volume":"298","author":"Das","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_116","unstructured":"Mara\u00f1\u00f3n, R.O., and Moulana, M. (2023). Manuscript in preparation; to be submitted."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568008043339947","article-title":"Treatment of inflammatory and paraproteinemic neuropathies","volume":"4","author":"Monaco","year":"2004","journal-title":"Curr. Drug Targets Immune Endocr. Metabol. Disord."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41577-019-0160-5","article-title":"Immune mechanisms of hypertension","volume":"19","author":"Drummond","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ajcn\/83.2.331","article-title":"Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men","volume":"83","author":"Rees","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1681\/ASN.2005091013","article-title":"T cells in crescentic glomerulonephritis","volume":"17","author":"Tipping","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1093\/ndt\/gfq203","article-title":"Circulating pro-inflammatory CD4posCD28null T cells are independently associated with cardiovascular disease in ESRD patients","volume":"25","author":"Betjes","year":"2010","journal-title":"Nephrol. Dial. Transplant"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/ATVBAHA.119.313032","article-title":"Low Levels of CD4+CD28null T Cells at Baseline Are Associated with First-Time Coronary Events in a Prospective Population-Based Case-Control Cohort","volume":"40","author":"Tomas","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/imm.12506","article-title":"The life (and death) of CD4+ CD28null T cells in inflammatory diseases","volume":"146","author":"Dumitriu","year":"2015","journal-title":"Immunology"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/1529-0131(199905)42:5<844::AID-ANR2>3.0.CO;2-M","article-title":"Arterial wall injury in giant cell arteritis","volume":"42","author":"Weyand","year":"1999","journal-title":"Arthritis Rheum."},{"key":"ref_125","unstructured":"Moulana, M. (2017). Unpublished work."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1161\/HYPERTENSIONAHA.115.05779","article-title":"Obligatory Role for B Cells in the Development of Angiotensin II-Dependent Hypertension","volume":"66","author":"Chan","year":"2015","journal-title":"Hypertension"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/HYPERTENSIONAHA.118.11828","article-title":"B-cell deficiency lowers blood pressure in mice","volume":"73","author":"Dingwell","year":"2019","journal-title":"Hypertension"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/HYPERTENSIONAHA.122.20001","article-title":"Peripheral Immune Cell Composition is Altered in Women Before and After a Hypertension Diagnosis","volume":"80","author":"Kresovich","year":"2023","journal-title":"Hypertension"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1757-2215-3-23","article-title":"Changes in androgens and insulin sensitivity indexes throughout pregnancy in women with polycystic ovary syndrome (PCOS): Relationships with adverse outcomes","volume":"3","author":"Falbo","year":"2010","journal-title":"J. Ovarian Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/humupd\/dml036","article-title":"A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"12","author":"Boomsma","year":"2006","journal-title":"Hum. Reprod. Updat."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"558.e1","DOI":"10.1016\/j.ajog.2011.03.021","article-title":"Pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis","volume":"204","author":"Kjerulff","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1477-7827-11-56","article-title":"Obstetric complications in women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"11","author":"Qin","year":"2013","journal-title":"Reprod. Biol. Endocrinol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum. Reprod. Updat."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/obr.12829","article-title":"Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity\u2014A systematic review, meta-analysis, and meta-regression","volume":"20","author":"Joham","year":"2019","journal-title":"Obes. Rev."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/humrep\/deaa099","article-title":"Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: A population-based study on 9.1 million pregnancies","volume":"35","author":"Mills","year":"2020","journal-title":"Hum. Reprod."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/01.HYP.0000258595.09320.eb","article-title":"High blood pressure in pregnancy and coronary calcification","volume":"49","author":"Sabour","year":"2007","journal-title":"Hypertension"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1097\/gme.0b013e3181ddf705","article-title":"Polycystic ovary syndrome and early-onset preeclampsia: Reproductive manifestations of increased cardiovascular risk","volume":"17","author":"Westerveld","year":"2010","journal-title":"Menopause"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1161\/CIRCULATIONAHA.111.044784","article-title":"Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: The Avon Longitudinal Study of Parents and Children","volume":"125","author":"Fraser","year":"2012","journal-title":"Circulation"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Yang, S.-W., Yoon, S.-H., Kim, M., Seo, Y.-S., and Yuk, J.-S. (2023). Risk of Gestational Diabetes and Pregnancy-Induced Hypertension with a History of Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051738"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"106347","DOI":"10.1016\/j.intimp.2020.106347","article-title":"Evaluation of T cell cytokines and their role in recurrent miscarriage","volume":"82","author":"Ali","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1006\/smim.2001.0316","article-title":"Pregnancy: Success and failure within the Th1\/Th2\/Th3 paradigm","volume":"13","author":"Raghupathy","year":"2001","journal-title":"Semin. Immunol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2741\/2737","article-title":"Cytokine imbalance in pregnancy complications and its modulation","volume":"13","author":"Raghupathy","year":"2008","journal-title":"Front. Biosci. Landmark"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1210\/jc.2014-1214","article-title":"Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: A prospective controlled clinical study","volume":"99","author":"Palomba","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Victor, V.M., Rovira-Llopis, S., Ba\u00f1uls, C., Diaz-Morales, N., De Mara\u00f1on, A.M., Rios-Navarro, C., Alvarez, A., Gomez, M., Rocha, M., and Hern\u00e1ndez-Mijares, A. (2016). Insulin resistance in PCOS patients enhances oxidative stress and leukocyte adhesion: Role of myeloperoxidase. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151960"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/clinem\/dgab684","article-title":"Changes in serum cytokines throughout pregnancy in women with polycystic ovary syndrome","volume":"107","author":"Stokkeland","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00006254-200103000-00018","article-title":"How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing\u2019s syndrome?","volume":"56","author":"Kaltsas","year":"2001","journal-title":"C Obstet. Gynecol. Surv."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/eje.0.1500363","article-title":"High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"150","author":"Janssen","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.fertnstert.2012.10.040","article-title":"Psoriatic patients have an increased risk of polycystic ovary syndrome: Results of a cross-sectional analysis","volume":"99","author":"Moro","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1210\/jc.2003-030398","article-title":"Hypothyroidism and atherosclerosis","volume":"88","author":"Cappola","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1524-6175.2006.05180.x","article-title":"Hyperthyroidism: A secondary cause of isolated systolic hypertension","volume":"8","author":"Prisant","year":"2006","journal-title":"J. Clin. Hypertens."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fendo.2019.00482","article-title":"Hypertension in Thyroid Disorders","volume":"10","author":"Berta","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_152","first-page":"GP199","article-title":"Cardiovascular risk factors in patients with autoimmune thyroiditis","volume":"49","author":"Neves","year":"2017","journal-title":"Endocr. Abstr."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Ho, C.W., Chen, H.H., Hsieh, M.C., Chen, C.C., Hsu, S.P., Yip, H.T., and Kao, C.H. (2020). Increased risk of polycystic ovary syndrome and It\u2019s comorbidities in women with autoimmune thyroid disease. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17072422"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum. Reprod."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1210\/en.2015-1159","article-title":"Hyperandrogenism and insulin resistance, not changes in body weight, mediate the development of endothelial dysfunction in a female rat model of polycystic ovary syndrome (PCOS)","volume":"156","author":"Hurliman","year":"2015","journal-title":"Endocrinology"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/1947-2714.161246","article-title":"Anti-Inflammatory Dietary Combo in Overweight and Obese Women with Polycystic Ovary Syndrome","volume":"7","author":"Salama","year":"2015","journal-title":"N. Am. J. Med. Sci."},{"key":"ref_159","first-page":"e1844","article-title":"New therapeutic approaches in obesity and metabolic syndrome associated with polycystic ovary syndrome","volume":"9","author":"Saleem","year":"2017","journal-title":"Cureus"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1161\/01.CIR.98.24.2709","article-title":"Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure","volume":"98","author":"Hambrecht","year":"1998","journal-title":"Circulation"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1161\/01.CIR.0000074229.93804.5C","article-title":"Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase","volume":"107","author":"Hambrecht","year":"2003","journal-title":"Circulation"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.2004.068197","article-title":"Effect of exercise training on endothelium-derived nitric oxide function in humans","volume":"561","author":"Green","year":"2004","journal-title":"J. Physiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s12265-018-9794-0","article-title":"Effect of Aerobic Exercise on Treg and Th17 of Rats with Ischemic Cardiomyopathy","volume":"11","author":"Chen","year":"2018","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fendo.2019.00200","article-title":"Circulating Endothelial Microparticles Reduce in Concentration Following an Exercise Program in Women with Polycystic Ovary Syndrome","volume":"10","author":"Kirk","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.biochi.2014.10.028","article-title":"Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise","volume":"124","author":"Covington","year":"2016","journal-title":"Biochimie"},{"key":"ref_166","first-page":"3506","article-title":"Effect of aerobic exercise on inflammatory markers in polycystic ovary syndrome: A randomized controlled trial","volume":"26","author":"Elbandrawy","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"5561980","DOI":"10.1155\/2021\/5561980","article-title":"Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome","volume":"2021","author":"Li","year":"2021","journal-title":"Int. J. Endocrinol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/humrep\/des138","article-title":"The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome","volume":"27","author":"Thomson","year":"2012","journal-title":"Hum. Reprod."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3389\/fphys.2019.01550","article-title":"Inflammatory Effects of High and Moderate Intensity Exercise-A Systematic Review","volume":"10","author":"Cerqueira","year":"2020","journal-title":"Front. Physiol."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/4\/1010\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:15:28Z","timestamp":1760123728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/4\/1010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":169,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["life13041010"],"URL":"https:\/\/doi.org\/10.3390\/life13041010","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]}}}